All Immunology articles – Page 4
-
NewsPrize winner’s research reveals microbiota’s hidden role in in mosquito-borne disease
For his work in revealing the hidden role of the microbiota in mosquito-borne disease, Yibin Zhu is the winner of the 2026 Noster NOSTER & Science Microbiome Prize. Microbiota from both the hosts and vectors can either promote or suppress virus transmission, depending on where they act in the transmission cycle.
-
NewsCOVID’s lingering shadow faded after Omicron — but not for everyone
A long-term study of long Covid has found that whilst lingering symptoms became far less common after the Omicron variant arrived, some people have continued to experience health problems years after infection.
-
ArticleCOVID-19 vaccine boosters may help protect against future animal coronaviruses
COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 but may also help protect against some future coronaviruses that risk spreading from animals to humans, researchers have shown.
-
NewsCommon probiotic ingredient turns immune cells into tumor killers
A probiotic bacterium secretes mannose—that significantly suppresses melanoma growth in mice by activating the body’s own immune defenses. Mannose enters CD8⁺ T cells through glucose transporters and inhibits a key protein called YAP1, which normally restrains T-cell killing power.
-
NewsStudy: Three-in-one vaccine shows promise against ‘tripledemic’
A single-shot vaccine in development could protect against flu, COVID-19 and RSV simultaneously. In a study, researchers found that their three-in-one vaccine triggered protective immunity against all three respiratory diseases in mice, ferrets and cotton rats.
-
![Low-Res_[1] KRICT Research Team](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/3/0/4/21304_lowres_1krictresearchteam_295027.jpg)
NewsKRICT discovers novel SRV2 envelope protein for efficient car immune cell production
Researchers identify a novel SRV2 envelope protein that serves as a key to unlock immune cells, enabling more efficient delivery of anticancer genes and improving the production and therapeutic performance of CAR immune cells.
-
NewsGut microbiome: The hidden architect of liver cancer immunotherapy response
A comprehensive review synthesizes current advances linking gut bacteria to immunotherapy outcomes in hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
-
NewsBillions of doses later: Global review confirms mRNA vaccines are safe, effective and full of promise
A comprehensive review brings together global evidence to strengthen public trust and counter misinformation as mRNA vaccines expand to prevent and treat more diseases.
-
NewsAntibiotics reverse damage caused to blood stem cells by chronic Salmonella
A new study has revealed that long-term Salmonella infections severely damage blood stem cells - but this damage is completely reversible. Giving an effective course of antibiotics fully restores the stem cells, allowing them to recover their health and rebuilding power.
-
NewsCase study: Fatal rabies in a child
Ontario’s first case of fatal rabies since 1967 provides critical guidance to help prevent death from rabies in future instances. The parents agreed to share their son’s case to help raise awareness of rabies.
-
NewsSea anemone flips a human antiviral strategy on its head
A new study has uncovered a previously unknown antiviral defense mechanism in sea anemones, revealing that animals may have evolved more than one way to fight viral infections.
-
NewsNatural compound may help boost vaccine responses
A team of researchers has found that the naturally occurring compound spermidine can help boost vaccine response in older adults by reducing molecular markers of immune system ageing.
-
NewsHealthy infant microbiomes appear to protect against malaria
A small preliminary study shows that 6-week-old infants with healthy gut microbiomes are less likely to contract malaria in their first year of life, suggesting the intriguing possibility that treatments such as probiotics could be protective against malaria.
-
NewsMicrobes rewrite the rules of cancer immunotherapy by triggering immunogenic cell death
A new study reveals that microbiota and their metabolites can effectively reprogram immunogenic cell death (ICD), a unique form of cell death that activates the body‘s immune system against tumors, transforming immunologically “cold” therapy-resistant tumors into “hot” responsive ones.
-
NewsRed meat may worsen IBD — here’s what could help
New research sheds light on why red meat may worsen inflammatory bowel disease (IBD). Researchers found that mice fed a beef-based diet developed the most severe intestinal inflammation, but those consuming pea protein showed only mild symptoms.
-
NewsDiscovery of severe pneumonia subtypes could lead to tailored treatments for life-threating disease
New research shows that severe pneumonia has three different subtypes, helping explain why some patients in intensive care units (ICUs) recover quickly, while for other patients the disease can be life-threatening.
-
NewsHidden protein linked to severe COVID-19 and lung disease risk
A genetic difference carried by nearly one in three people may increase the risk of severe COVID-19 and lung fibrosis by disrupting the function of a previously unknown protein, according to a new study.
-
NewsThe early immune clues that determine who develops TB
An early view of the immune response to bacteria in the lungs provides clues as to why some people keep TB in check, while others develop disease, suggesting new ways to intervene earlier and stop TB.
-
NewsGut fungi may hold the key to treating asthma worldwide
Two new studies reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases — and may be promising targets for new therapies.
-
NewsResearch team awarded NIH grant to study congenital CMV transmission during pregnancy
A research team has received a new 5-year, $3.87 million R01 grant from the National Institutes of Health (NIH) to investigate how the immune system protects against congenital cytomegalovirus (CMV) infection.